derivatives appear to enhance that activity, "we have no toxicology information on those derivatives. It's worth pursuing but not really much of a shortcut, at least not as envisioned. Still, it's a new platform."
Before treating patients with pathogen-specifıc antibiotic agentswhether standard, novel, or repurposed-one should know precisely what pathogen is causing their infections and to which antibiotics it is sus-ceptible. Bacteriophage can provide a rapid and highly specifıc way to determine those susceptibilities, according to Herbert Schweitzer of the University of Florida, Gainesville. For instance, he maintains a collection of phages that target the bacterial pathogen and select agent Burkholderia pseudomallei. By adding appropriate drugs to plates growing this pathogen and then adding phages, which replicate "only on live cells," he says, "we can detect [drugresistant] Burkholderia very rapidly." This drug susceptibility test can be run with rapid diagnostic procedures such as MALDI-TOF mass spectrometry to fırst identify the bacterial pathogen.
Komodo dragons and alligators, ancient species dating back some 55 million years, are a source of potentially useful, and in their own way novel, antimicrobial agents, according to Ryan Blower of George Mason University in Manassas, Va. The blood of these species carries hundreds of cationic antimicrobial peptides, which Blower and his collaborators are screening for further development. They then combine the more promising among these peptides with lipid-specifıc particles to enhance their interactions with microbial membranes, he says. Small chemical changes can further improve the antimicrobial activity, which depends mainly on membrane disruption. Fearing that some active agents are lost in transit from alligator farms in Florida, he adds, the George Mason group is considering farming its own animals locally to provide fresher blood samples that perhaps will contain novel activities.
Jeffrey L. Fox is the Microbe Current Topics and Features Editor.
RESEARCH ADVANCES

Infecting Pregnant Mice Disrupts Fetal Brain, Inducing Autism Shannon Weiman
Infecting pregnant mice can activate immune responses that disrupt fetal brain development, causing autism spectrum disorder (ASD)-like syndrome in newborn mice, according to Gloria Choi of Massachusetts Institute of Technology in Cambridge, Mass., and her collaborators there and at several other institutions. The inflammatory cytokine IL-17a orchestrates that pathology, a fınding with implications for preventive and therapeutic strategies if the mechanism in mice applies to humans, they say. Details appeared online 28 January 2016 in Science (doi: 10.1126/science.aad0314).
"Numerous animal studies demonstrate that prenatal infections can result in acute and persistent neurological and behavioral abnormalities in offspring resembling ASD or schizophrenia," says Brian Lee of Drexel University in Philadelphia, Pa., who was not involved in this research. "This work provides a really intriguing chain of causation, from immunological mediators, to abnormal brain development, to behavioral abnormalities, that together elegantly explains the epidemiological observation that maternal viral infection during pregnancy increases risk of offspring autism."
Prenatal infections with rubella virus, cytomegalovirus, and the parasite Toxoplasma gondii can exert teratogenic effects on brain development. However, despite well-recognized correlations since the 1970s between pregnant women becoming infected with viruses such as the measles, mumps, or influenza viruses and their babies having ASD, the mechanism underlying this phenomenon remains elusive. Further, children of mothers hospitalized for infection of any kind during pregnancy have a 30% higher risk of ASD, Lee reports. Recent evidence implicates diverse infectious agents, including viruses, bacteria, and fungi, rather than specifıc neurotropic viruses-suggesting an unspecifıc disease process underlying these associations, he says.
Searching for a molecular mechanism, Choi and colleagues injected pregnant mice with synthetic double-
MINITOPIC
AAM Report: High Impact of Next-Gen Sequencing in Clinical Microbiology
The ASM American Academy of Microbiology (AAM) in February released a report, "Applications of Clinical Microbial Next-Generation Sequencing," predicting that next-generation DNA sequencing (NGS) will have a big impact on clinical microbiology. This technology, when used for identifying microbial pathogens, "has the capacity to provide crucial clinical benefits in patient care, patient outcomes, and public health," according to the report. "Clinical laboratories must find ways to overcome operational, technical, regulatory, and strategic challenges in order to effectively employ NGS-based diagnostic tests," it further notes. "Moving the NGS process from the research lab to widespread clinical application is the payoff of the remarkable odyssey of DNA sequencing breakthroughs over the last decade," says George Weinstock of the Jackson Laboratory in Farmington, Conn., who chaired the AAM Colloquium Steering Committee whose members wrote the report. "But there are major obstacles, which the report lays out and suggests how to combat." To download the report, go to http://academy. asm.org/images/Colloquia-report/NGS_ Report.pdf. stranded RNA-to mimic a viral infection-inducing ASD-like symptoms in pups, including abnormalities in brain development as well as behavior and social interactions that persist into adulthood. These symptoms in newborn mice are accompanied by altera-tions in immune signaling-specifıcally, IL-17a receptors are upregulated in cortical layers of the brains, where structural defects arise, of the developing fetuses. Expression of IL-17a also is enhanced in maternal mononuclear cells throughout the placenta and uter-us. "These fındings raise the possibility that modulation of IL-17a in the CNS can influence neuronal development, with implications as to specifıc neuronal cell types and their connectivity," she says.
Other evidence implicates cytokines and IL-17a in human cases of ASD, according to Lee. "Dysregulated levels of various inflammatory markers in maternal sera or amniotic fluid during pregnancy are associated with increased risk of ASD," he says. Further, cytokines influence neuronal migration, synapse formation, and neuronal survival. "Dysregulated levels of cytokines during development due to maternal infections therefore may adversely affect neurobehavioral function," he says.
Children with ASD have similar immune abnormalities, Choi adds. "Elevated levels of IL-17a have been detected in the serum of a subset of autistic children." IL-17 is also implicated in numerous autoimmune diseases in humans, including rheumatoid arthritis, irritable bowel syndrome, and multiple sclerosis. Based on results in mice with ASD, therapeutics against these diseases, including antibodies against IL-17 and the upstream IL-6 receptor, might prove useful in treating ASD, according to Choi.
Shannon Weiman is a freelance writer in San Francisco, Calif.
NEW FROM ASM
Sequencing, Not Culture, Proved Fast Way To Find New Hot Spring Virus Carol Potera
Culture-independent methods are making it possible to discover and partly characterize viruses and their hosts straight from hot springs such as those in Yellowstone National Park (YNP)-short-circuiting the traditional approach that depends on fırst growing samples in vitro, according to Rebecca Hochstein at Montana State
MINITOPIC
Zika Virus Update: Research, Models, Diagnostics
Amid rising concern over the rapid geographic spread of the Zika virus and expanding public health risks from outbreaks that it is causing, related research and other activities are surging. Recent examples include: 
